November 20, 2017 / 12:48 PM / a month ago

BRIEF-Geron says first patient dosed in expanded part 1 of imerge clinical trial in myelodysplastic syndromes

Nov 20 (Reuters) - Geron Corp:

* Geron announces first patient dosed in expanded part 1 of imerge clinical trial in myelodysplastic syndromes Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below